FGMCR vs IDXX
FG Merger II Corp. Rights (FGMCR) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
FG Merger II Corp. Rights (FGMCR) common stock listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
FGMCR does not have a complete income-statement cache yet.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
FGMCR currently screens at market cap $0. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the FGMCR and IDXX stock pages for the full models.
Not investment advice.